Posts Tagged ‘latest’
Fewer Headaches On The Horizon Thanks To Latest Guidelines
If you’re one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That’s because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment…
Fewer headaches on the horizon, thanks to latest guidelines
If you’re one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That’s because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment.
Statement By The Welsh Assembly Government On Latest Developments In Respect Of The Influenza A (H1N1) Swine Flu Pandemic
This statement updates Members on latest developments in respect of the Influenza A (H1N1) swine flu pandemic. The latest GP consultation rates in Wales for flu-like illness have decreased and are now steady, although still a little above the usual rates for the time of year. On the 26th November, 77 people were in hospital with swine flu, 14 of those in critical care…
CNSBio Inc. To Present Latest Clinical Trial Data For CNSB015 At Neuropathic Pain Conference In San Francisco
CNSBio Inc. will present recent Phase IIa proof-of-concept clinical trial data for CNSB015, an orally administered potassium channel modulator used in combination with opioids for the treatment of neuropathic pain, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain on November 20-21, 2009 in San Francisco, CA. Dr.
Officials And The Public Should Use The Latest Evidence As A Guide In H1N1 Prevention And Protection Procedures: Scientific Community Recommendation
As flu season draws nearer along with the potential for resurgence in H1N1, leading infectious diseases doctors, hospital epidemiologists, and infection preventionists urge officials to base recommendations for the public and healthcare workers on scientific knowledge and frontline experience gained from the outbreak this summer.
Latest Replikins Data Predicts Continued High Level Of H1N1 (Swine Flu) Infectivity And Lethality
Biotech firm Replikins Ltd. released its analysis of the June and July genomic data that predicts the rates of infectivity and lethality of the H1N1 (Swine Flu) virus. The quantitative analysis shows continued elevated levels in the Replikin Counts* of both Infectivity and Lethality genes, which indicate that the end of the current outbreak is not yet in sight.
Latest Swine Flu Advice, UK
Since being declared a pandemic earlier this month, swine flu has continued to cause concern for many people across the world, not least those in high risk groups such as people with diabetes. Now renamed influenza A(H1N1), swine flu is a respiratory disease that could lead to complications such as bronchitis and pneumonia. It has some elements of a virus found in pigs but cannot be transferred from pigs to humans.
Physicians Alerted To Latest Clinical Information On H1N1 Flu By Unique Electronic Strategy
History was made at 2:30 p.m. (EDT) on Wednesday, April 29, when more than 3,000 physicians in Indianapolis were sent a broadcast alert on swine flu (H1N1 virus) from the Marion County Health Department. The message was of critical importance to patient care; history was made in the way it was transmitted and received.
Latest Research Findings At The American Academy Of Orthopaedic Surgeons Annual Meeting
Leading orthopedic surgeons and other clinicians from Rush University Medical Center are presenting new basic and clinical research findings at the American Academy of Orthopaedic Surgeons annual meeting in Las Vegas, Nev., on February 25-28. Highlights from some of the educational sessions led by orthopedic experts from Rush as well as some of the podium and poster presentations to be made by physicians from Rush include: Dr.
The Latest DRX9000? Study Data Published In Peer-Reviewed Journal!
A study titled, “Prospective Evaluation of the Efficacy of Spinal Decompression via the DRX9000? for Chronic Low Back Pain” was published in the December issue of The Journal of Medicine. The study authored by Dr. John Leslie, Mayo Clinic, et al, was designed to evaluate the effectiveness and safety of the DRX9000? in the treatment of chronic lower back pain. Patients enrolled in the study had suffered an overall average of 266 weeks of low back pain.
Rx Drug Compare
Translator
By N2H